Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis.
Journal Information
Full Title: Crit Rev Oncol Hematol
Abbreviation: Crit Rev Oncol Hematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosures Dr. Tagliamento reported travel grants from Roche, Bristol-Myers Squibb, AstraZeneca, Takeda and Honoraria as medical writer from Novartis, Amgen outside the submitted work. Dr. Lambertini acted as a consultant for Roche, Novartis, Lilly and AstraZeneca, and received honoraria from Novartis, Pfizer, Takeda, Roche, Sandoz and Lilly outside the submitted work."
Funding Disclosure
Evidence found in paper:
"Funding This study received no funding."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025